Literature DB >> 20534460

Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.

Philomena Arrenberg1, Ramesh Halder, Yang Dai, Igor Maricic, Vipin Kumar.   

Abstract

TCR-mediated recognition of beta-linked self-glycolipids bound to CD1d is poorly understood. Here, we have characterized the TCR repertoire of a CD1d-restricted type II NKT cell subset reactive to sulfatide involved in the regulation of autoimmunity and antitumor immunity. The sulfatide/CD1d-tetramer(+) cells isolated from naïve mice show an oligoclonal TCR repertoire with predominant usage of the Valpha3/Valpha1-Jalpha7/Jalpha9 and Vbeta8.1/Vbeta3.1-Jbeta2.7 gene segments. The CDR3 regions of both the alpha- and beta-chains are encoded by either germline or nongermline gene segments of limited lengths containing several conserved residues. Presence of dominant clonotypes with limited TCR gene usage for both TCR alpha- and beta-chains in type II NKT cells reflects specific antigen recognition not found in the type I NKT cells but similar to the MHC-restricted T cells. Although potential CD1d-binding tyrosine residues in the CDR2beta region are conserved between most type I and type II NKT TCRs, CDR 1alpha and 3alpha regions differ significantly between the two subsets. Collectively, the TCR repertoire of sulfatide-reactive type II NKT cells exhibits features of both antigen-specific conventional T cells and innate-like cells, and these findings provide important clues to the recognition of beta-linked glycolipids by CD1d-restricted T cells in general.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534460      PMCID: PMC2890761          DOI: 10.1073/pnas.1000576107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.

Authors:  Dale I Godfrey; Jamie Rossjohn; James McCluskey
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

Review 2.  Spectratype/immunoscope analysis of the expressed TCR repertoire.

Authors:  Jeffrey R Currier; Mary Ann Robinson
Journal:  Curr Protoc Immunol       Date:  2001-05

3.  Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size.

Authors:  J L Matsuda; L Gapin; N Fazilleau; K Warren; O V Naidenko; M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

4.  T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire.

Authors:  Thierry Mallevaey; James P Scott-Browne; Jennifer L Matsuda; Mary H Young; Daniel G Pellicci; Onisha Patel; Meena Thakur; Lars Kjer-Nielsen; Stewart K Richardson; Vincenzo Cerundolo; Amy R Howell; James McCluskey; Dale I Godfrey; Jamie Rossjohn; Philippa Marrack; Laurent Gapin
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

5.  Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.

Authors:  Daniel G Pellicci; Onisha Patel; Lars Kjer-Nielsen; Siew Siew Pang; Lucy C Sullivan; Konstantinos Kyparissoudis; Andrew G Brooks; Hugh H Reid; Stephanie Gras; Isabelle S Lucet; Ruide Koh; Mark J Smyth; Thierry Mallevaey; Jennifer L Matsuda; Laurent Gapin; James McCluskey; Dale I Godfrey; Jamie Rossjohn
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

6.  Immunodominance in the TCR repertoire of a [corrected] TCR peptide-specific CD4+ Treg population that controls experimental autoimmune encephalomyelitis.

Authors:  Loui Thomas Madakamutil; Igor Maricic; Eli E Sercarz; Vipin Kumar
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

7.  Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer.

Authors:  David H Chang; Haiteng Deng; Phillip Matthews; Joseph Krasovsky; Govind Ragupathi; Radek Spisek; Amitabha Mazumder; David H Vesole; Sundar Jagannath; Madhav V Dhodapkar
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

8.  Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma.

Authors:  Gourapura J Renukaradhya; Masood A Khan; Marcus Vieira; Wenjun Du; Jacquelyn Gervay-Hague; Randy R Brutkiewicz
Journal:  Blood       Date:  2008-04-16       Impact factor: 22.113

9.  Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.

Authors:  Maria Blomqvist; Sara Rhost; Susann Teneberg; Linda Löfbom; Thomas Osterbye; Manfred Brigl; Jan-Eric Månsson; Susanna L Cardell
Journal:  Eur J Immunol       Date:  2009-07       Impact factor: 5.532

10.  The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families.

Authors:  S H Park; A Weiss; K Benlagha; T Kyin; L Teyton; A Bendelac
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more
  69 in total

Review 1.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

2.  Distinct PLZF+CD8αα+ Unconventional T Cells Enriched in Liver Use a Cytotoxic Mechanism to Limit Autoimmunity.

Authors:  Huiming Sheng; Idania Marrero; Igor Maricic; Shaohsuan S Fanchiang; Sai Zhang; Derek B Sant'Angelo; Vipin Kumar
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

3.  Combined deletion of Id2 and Id3 genes reveals multiple roles for E proteins in invariant NKT cell development and expansion.

Authors:  Jia Li; Di Wu; Ning Jiang; Yuan Zhuang
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

4.  Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.

Authors:  Igor Maricic; Enrico Girardi; Dirk M Zajonc; Vipin Kumar
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

Review 5.  Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Luc Van Kaer; Lan Wu; Vrajesh V Parekh
Journal:  Immunology       Date:  2015-06-22       Impact factor: 7.397

Review 6.  Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions.

Authors:  Patrick J Brennan; Manfred Brigl; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2013-01-21       Impact factor: 53.106

Review 7.  Commensal microbiota and NKT cells in the control of inflammatory diseases at mucosal surfaces.

Authors:  Sebastian Zeissig; Richard S Blumberg
Journal:  Curr Opin Immunol       Date:  2013-11-05       Impact factor: 7.486

8.  Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation.

Authors:  Shiny Nair; Chandra Sekhar Boddupalli; Rakesh Verma; Jun Liu; Ruhua Yang; Gregory M Pastores; Pramod K Mistry; Madhav V Dhodapkar
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

9.  Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response.

Authors:  Jie Zhao; Xiufang Weng; Sreya Bagchi; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 10.  Recognition of CD1d-restricted antigens by natural killer T cells.

Authors:  Jamie Rossjohn; Daniel G Pellicci; Onisha Patel; Laurent Gapin; Dale I Godfrey
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.